Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 79.76

-2.1%

4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2195)	1/23/2008 9:36:39 AM
From: Jibacoa	of 3722

ABT opened down 1% in spite of reporting earnings in line with its previous guidance.<g> stockcharts.com ABT 4thQ earnings were as expected, $1.20B ($0.77) vs, loss of $476M ($0.31) in 2006 when it reported charges related to its purchase of Kos. Excluding special items,ABT earnings were $0.93/shr.(Its forecast was around $0.91 to $0.93) It is expected that sales of Humira will rise to $4B in 2008, as the drug continues to compete against JNJ's Remicade & WYE's Enbrel. Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next